Metabolic Adverse Events Associated With Antipsychotic Polypharmacy Versus Monotherapy Among New Pediatric Users

Annals of Epidemiology and Public Health
doi 10.33582/2639-4391/1003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MedDocs Publishers LLC

Related search

Antipsychotic Patterns of Use in Patients With Schizophrenia: Polypharmacy Versus Monotherapy

BMC Psychiatry
PsychiatryMental Health
2014English

Antipsychotic Monotherapy and Polypharmacy in the Naturalistic Treatment of Schizophrenia With Atypical Antipsychotics

BMC Psychiatry
PsychiatryMental Health
2005English

Costs Associated With Adverse Events Among Acute Patients

BMC Health Services Research
Health Policy
2017English

Is Antipsychotic Polypharmacy Associated With Metabolic Syndrome Even After Adjustment for Lifestyle Effects?: A Cross-Sectional Study

BMC Psychiatry
PsychiatryMental Health
2011English

Pediatric Adverse Tracheal Intubation Associated Events Following Noninvasive Ventilation Failure

Pulmonary and Critical Care Medicine
2016English

Antipsychotic Polypharmacy - Confusion Reigns

Psychiatrist
PsychiatryMental Health
2010English

Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Pediatric Polypharmacy

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2008English

Discrepancy Among Observational Studies: Example of Naproxen-Associated Adverse Events

Open Rheumatology Journal
Rheumatology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy